Mid Hospitals
Market Cap
₹64,587 ₹64,587 Cr.
P/E
202.67
PEG
8.81
PEG = P/E ÷ 5yr forward EPS CAGR
5yr forward EPS CAGR thesis · Base case

The thesis turns live if the planned bed additions are commissioned on schedule and new capacity converts into sustained occupancy and patient volumes.

The bull path requires faster capacity ramp and stronger revenue per patient, whereas the bear path reflects commissioning delays and volume shortfalls.

Margin expansion depends on mature-hospital mix, procurement and fixed-cost synergies, while startup losses and competition constrain upside.

Key Ratios

Debt to Equity
Debt to Equity
0.17
Div Yield (%)
Div Yield (%)
0.40
Individual < 2 lac
Individual < 2 lac
3.00 %
Institutions
Institutions
38.18 %
Market cap
Market cap
64,587 Cr
No. of Shareholders
No. of Shareholders
1.33 L
OPM (%)
OPM (%)
19.65 %
PE
PE
202
Prom Holding
Prom Holding
40.39 %
ROCE (%)
ROCE (%)
10.87
ROE (%)
ROE (%)
8.48
Sales
Sales
4,876 Cr
  • Aster DM Quality
  • Fortis Healthcare
  • Global Health
  • TJI Hospitals
Last updated on 16 Sep 2026
  • Aster DM Quality Care runs hospitals and clinics, with labs and pharmacy as small ancillaries. Hospitals and clinics bring ~95% of FY26 revenue of ~₹9,273Cr.
  • It runs 39 hospitals in 28 cities across South and Central India with ~10,890 beds. Its care spans oncology, cardiac, neuro, gastro, ortho and mother-child services.
  • It was formed in FY26 by a merger that combined four hospital brands. The combined company was renamed Aster DM Quality Care.
  • Profit rests on mature beds, about 73% of beds at ~30% EBITDA margin. Synergies and a fast-growing service drive growth.
  • Per management, it is one of India's leading integrated healthcare providers, covering primary to quaternary care.
  • It is integrating the merged hospitals and expanding beds. Growth is aimed at a larger consolidated hospital base.
  • It is in merger digestion, with FY27 as the test year. Management guides ~₹150–200Cr of synergies and 24–25% EBITDA margin by FY28–FY29.
  • The promoter family holds 24.58%, just below the 25% open-offer trigger. A trustee holds encumbrance over 10.33% of capital against promoter-level loans.
  • Service scaling to double-digit share Each quarter
    It grows above 50% a year to a double-digit revenue share in 2–3 years.
  • FY27 merger synergies By FY27-end
    It adds ~₹150–200Cr of EBITDA, with progress each quarter.
  • Hospital bed expansion Staged FY27–FY30
    It adds 4,179 beds to about 10,890 today, about 38% of today's base.
  • Remaining TPG-backed seller stake sale No timeline
    Any further sale shows size and price against the 2 Sep block at ₹760 and who absorbs it.
  • Promoter stake crossing 25% No timeline
    Any further family buy forces an open offer.
Price Range

See where the stock is trading versus its 52-week high and low.

Low
519
52W Range
High
891
Timeline

Key company specific updates.

Custom financial statement

Edit rows

Forensics

10 Yes

Positive for this company

1 Neutral

Neutral for this company

6 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up - India

Location Wise Break-Up

Therapeutic Area Break-Up

Customer Segment

Operating Profit Break-Up

Asset Break-Up - Segment Wise

Asset Break-Up - Segment

Operational Metrics

    Select a Metric
    • Operational Beds (.)
    • Hospital Occupancy Rate (%)
    • Average Length Of Stay (Days)
    • Average Daily Revenue Per Occupied Bed (Rs)
    • No Of Pharmacies (.)
    • Number of Outpatient Visits - Quarterly (.)

    Peer Comparison

    Corporate Actions

    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less

    FAQs on Aster DM Quality Care Ltd. Business

    Aster DM Quality Care Ltd. (previously known as Aster DM Healthcare Ltd.) is one of India's largest integrated healthcare providers, operating hospitals, clinics, pharmacies and diagnostic centers. Following its merger with Quality Care India, it manages leading hospital brands including Aster, CARE, KIMSHEALTH and Evercare.

    Aster DM Quality major competitors are Fortis Healthcare, Global Health, Narayana Hrudayalay., Krishna Inst.Medi, Max Healthcare Inst., RainbowChildrenS Med, Healthcare Global.
    Market Cap of Aster DM Quality is ₹64,587 Crs.
    While the median market cap of its peers are ₹37,878 Crs.

    Aster DM Quality seems to be financially stable compared to its competitors.
    The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

    Company Filing

    Discussions & Analysis

    Ideas Dashboard
    Results
    Timeline
    Watchlist
    Portfolio
    Alerts
    Stock Screener
    Market
    Raw Material